Evidence map›Paper›PMID 41606209›Full record

ArticleCommunications engineering2026

Photo-activated ultrasound localization imaging with laser-activated nanodroplets.

Shensheng Zhao, Junxi Yi, Yueying Qiu, Zihao Huang, Yun-Sheng Chen

Abstract read
In one paragraph

Article in Communications engineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Endothelial Continuum and Capillary Specialization in Pulmonary Vascular Development.Arteriosclerosis, thrombosis, and vascular biology · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Shensheng ZhaoDepartment of Electrical and Computer Engineering, Grainger College of Engineering, University of Illinois Urbana-Champaign, Urbana, IL, USA.
Junxi YiBeckman Institute for Advanced Science and Technology, University of Illinois Urbana-Champaign, Urbana, IL, USA.
Yueying QiuDepartment of Electrical and Computer Engineering, Grainger College of Engineering, University of Illinois Urbana-Champaign, Urbana, IL, USA.
Zihao HuangDepartment of Electrical and Computer Engineering, Grainger College of Engineering, University of Illinois Urbana-Champaign, Urbana, IL, USA.
Yun-Sheng ChenDepartment of Electrical and Computer Engineering, Grainger College of Engineering, University of Illinois Urbana-Champaign, Urbana, IL, USA. yunsheng@illinois.edu.ORCID http://orcid.org/0000-0001-8823-970X

Funding

National Science Foundation (NSF) CBET 24-42459 CARU.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (National Institute of Diabetes & Digestive & Kidney Diseases) 1R01DK138939-01
6 · The paper itself

Abstract

Super-resolution ultrasound localization (UL) imaging enables microvascular visualization beyond the acoustic diffraction limit, but is limited by the short circulation time and uneven distribution of microbubbles. Here, we present photo-activated UL (PaUL) imaging using laser-triggered nanodroplets for super-resolved imaging with precise spatiotemporal control. We synthesized dual-contrast indocyanine green (ICG)-encapsulated perfluoropentane nanodroplets and developed a programmable activation and imaging sequence. PaUL imaging achieved 21 µm spatial resolution and enabled on-demand contrast generation by tuning laser fluence. Compared to conventional UL imaging, PaUL imaging provided 2.4× faster vascular reconstruction and 1.6× longer tracking lengths in hemodynamic mapping. Its extended circulation time allowed up to 3× more localization events across imaging windows exceeding 20 minutes. Overall, PaUL imaging offers flexible, high-resolution contrast and can be integrated with photoacoustic imaging to enhance multimodal capabilities. This technique holds promise for microvascular imaging and image-guided therapeutic applications such as targeted drug delivery.

Identifiers

PMID41606209
PMCPMC12953887

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.